Head-to-head · Value Score
CoreAge Rx vs Collective
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Collective a 75. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameCollective
#140 · Grade C+ · Fair Price
Est. first month
$59 (semaglutide) plus a required $199-a-year membership
Save ~96% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 75 — an est. $99/mo first month, with no teaser step-up baked in. Collective isn't out of it: Shoppers willing to do the annual arithmetic, since the medication is genuinely cheap and the membership is what turns $59 a month into roughly $76.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Collective |
|---|---|---|
| Value Score | 93 (A+) | 75 (C+) |
| Est. first month | $99/mo | $59 (semaglutide) plus a required $199-a-year membership |
| Save vs brand-name | ~89% | ~96% |
| Semaglutide | $99/mo | $59/mo month-to-month plus a separate fee — a required $199-a-year membership |
| Tirzepatide | $149/mo | $69/mo month-to-month plus a separate fee — a required $199-a-year membership |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Collective
The cheapest published medication figures anywhere on this site — $59 a month for semaglutide, $69 for tirzepatide — attached to a required $199-a-year membership that the headline carrying the whole site leaves out.
Why it's a deal
- The medication figures are the lowest published on this site: $59 a month for compounded semaglutide and $69 for tirzepatide, both standing rates with no introductory window and no step-up
- Even with the membership added, twelve months of semaglutide comes to $907, about $76 a month — which is still below almost every all-in figure published elsewhere here
- The membership is disclosed on the product cards and answered plainly in the questions, and it is annual rather than a monthly fee stacked on a monthly fee
- A twenty-one-day trial lets a buyer see the service before the annual charge lands, and canceling online keeps the account active through the period already paid for
- The medical group is named in the privacy notice, the company's legal entity and street address are published, and a real phone number is answered under the brand
- An anti-nausea medication is prescribed alongside where it helps, which is a clinical courtesy rather than an upsell
The fine print
- The headline the site is built on, "Get GLP-1s at $59/month", omits a mandatory $199-a-year membership. The figure is true and the sentence is not, and the membership appears only in a card panel, a disclaimer and the questions
- The terms reserve a "nominal, uniform technology transaction fee" for every electronic prescription transmission and never say what it is, while the homepage promises no hidden costs and the questions say nothing is bolted on top
- The membership auto-renews annually, all membership fees are non-refundable, and there is no partial-period refund — so "cancel anytime" stops the next year rather than recovering this one
- No pharmacy is named and no 503A or 503B designation appears anywhere on the site: the strings do not occur at all, which for a $59 medication is the disclosure that matters most
- No state claim is made anywhere in the marketing. The only published list is the menu in the contact form, and a menu is not a promise that every jurisdiction on it is served
- The site's own savings claims disagree with each other — "up to 84%" on the homepage against "up to 86%" in the signup — and the comparison chart's unlabeled column is the tirzepatide basket, which is the more flattering of the two
- The billing cadence is never stated in days anywhere on the site, so whether a month is a calendar month or four weeks is unresolved
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Collective.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.